Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biorestorative Therapies Inc (NQ: BRTX )

3.280 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 3.280
Bid (Size) 3.090 (1)
Ask (Size) 3.700 (1)
Prev. Close 3.280
Today's Range 3.280 - 3.280
52wk Range 2.460 - 5.975
Shares Outstanding 3,673,629
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
What Is Autologous Cell-Based Therapy, The Treatment Revolutionizing Regenerative Medicine That Could Be Set To Explode Over The Next Few Years?
Successful Autologous Cell-Based Therapies 
Via Benzinga
EXCLUSIVE: BioRestorative Seeks Expanded FDA Approval For BRTX-100 Clinical Application, Engages Advisory Firm
BioRestorative Therapies Inc (NASDAQ: BRTX) has entered into an agreement with Bruder Consulting & Venture Group, a full-service strategic advisory, to assist the company in seeking FDA approval for... 
Via Benzinga

Performance

YTD
+20.59%
+20.59%
1 Month
+16.31%
+16.31%
3 Month
+15.03%
+15.03%
6 Month
+28.63%
+28.63%
1 Year
-39.71%
-39.71%

More News

Read More
BRTX’s ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome
Via TheNewswire.com
BRTX's ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Why BioRestorative Therapies Stock Is Climbing Higher Today
Via Benzinga
BioMedNewsBreaks – BioRestorative Therapies Inc. (NASDAQ: BRTX) Receives Notice of Third US Patent Related to ThermoStem IP
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Dow Jumps Over 300 Points; Best Buy Profit Beats Views
Via Benzinga
Why Cano Health Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Dow Rises 100 Points; Macy's Posts Upbeat Earnings
Via Benzinga
BioRestorative Therapeutics (BRTX) Stock Soars 40% on Patent News
Via InvestorPlace
Wall Street Mixed At Open; US Weekly Jobless Claims Decline
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
EXCLUSIVE: BioRestorative To Receive Third US Patent For Metabolic ThermoStem Program
Via Benzinga
BioRestorative Therapies: This Biopharma Company Is Helping Your Body Heal Itself
Via Benzinga
BioRestorative Therapies Inc (NASDAQ: BRTX) Announces European Patentability Of ThermoStem® Program With Indications In Obesity And Type 2 Diabetes
Via TheNewswire.com
Topics Intellectual Property
Exposures Intellectual Property
BioRestorative Therapies Inc (NASDAQ: BRTX) Announces European Patentability Of ThermoStem® Program With Indications In Obesity And Type 2 Diabetes
Via News Direct
Topics Intellectual Property
Exposures Intellectual Property
BioRestorative Therapies Inc (NASDAQ: BRTX) Announces European Patentability Of ThermoStem® Program With Indications In Obesity And Type 2 Diabetes
Via Benzinga
BioMedNewsBreaks – BioRestorative Therapies Inc. (NASDAQ: BRTX) Eyes Continued Growth of Patent Family for ThermoStem(R) Program
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
EXCLUSIVE: BioRestorative Poised To Receive European Patent For ThermoStem Program
Via Benzinga
BioRestorative (NASDAQ: BRTX) Ramps Up Production In Anticipation Of Positive Phase 2 Results
Via News Direct
BioRestorative (NASDAQ: BRTX) Ramps Up Production In Anticipation Of Positive Phase 2 Results
Via TheNewswire.com
BioRestorative (NASDAQ: BRTX) Ramps Up Production In Anticipation Of Positive Phase 2 Results
Via Benzinga
2022 Was A Year Of Growth, Funding, And Positive Results For BioRestorative Therapies
Via TheNewswire.com
Topics Intellectual Property
Exposures Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.